<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/latestarticles/journal?journal=bmcmusculoskeletdisord&amp;quantity=&amp;format=rss&amp;version=">
        <title>BMC Musculoskeletal Disorders - Latest Articles</title>
        <link>http://www.biomedcentral.com/bmcmusculoskeletdisord/</link>
        <description>The latest research articles published by BMC Musculoskeletal Disorders</description>
        <dc:date>2012-02-09T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/13/16" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/13/15" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/13/14" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/13/13" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/13/12" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/13/11" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/13/10" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/13/9" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/13/8" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/13/7" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/13/16">
        <title>Hemiarthroplasty versus angle-stable locking compression plate osteosynthesis in the treatment of three- and four-part fractures of the proximal humerus in the elderly:  design of a randomized controlled trial.</title>
        <description>Background:
The optimal surgical management of dislocated three- and four-part fractures of the proximal humerus in elderly patients remains unclear. Most used techniques are hemiarthroplasty and angle-stable locking compression plate osteosynthesis. In the current literature there is no evidence available presenting superior results between hemiarthroplasty and angle-stable locking compression plate osteosynthesis in terms of speed of recovery, pain, patient satisfaction, functional outcome, quality of life or complications.
Methods:
A randomized controlled multicenter trial will be conducted. Patients older than 60 years of age with a dislocated three- or four-part fracture of the proximal humerus as diagnosed by X-rays and CT-scans will be included. Exclusion criteria are a fracture older than 14 days, multiple comorbidity, multitrauma, a pathological fracture, previous surgery on the injured shoulder, severely deranged function caused by a previous disease, &quot;head-split&quot; proximal humerus fracture [6,7] and unwillingness or inability to follow instructions. Participants will be randomized between surgical treatment with hemiarthroplasty and angle-stable locking compression plate osteosynthesis. Measurements will take place preoperatively and 3 months, 6 months, 9 months, 12 months and 24 months postoperatively. Primary outcome measure is speed of recovery of functional capacity of the affected upper limb using the Disabilities of Arm, Shoulder and Hand score (DASH). Secondary outcome measures are pain, patient satisfaction, shoulder function, quality of life, radiological evaluation and complications. Data will be analyzed on an intention-to-treat basis, using univariate and multivariate analyses.DiscussionBoth hemiarthroplasty and angle-stable locking compression plate osteosynthesis are used in the current treatment of dislocated three-and four-part fractures of the proximal humerus. There is a lack of level-1 studies comparing these two most-used surgical treatment options. This randomized controlled multicenter trial has been designed to determine which surgical treatment option provides the fastest recovery of functional capacity of the affected upper limb, and will provide better outcomes in pain, satisfaction, shoulder function, quality of life, radiological evaluation and complications.Trial registration numberThe trial is registered in the Netherlands Trial Registry (NTR2461)</description>
        <link>http://www.biomedcentral.com/1471-2474/13/16</link>
                <dc:creator>Paul Verbeek</dc:creator>
                <dc:creator>Inge van den Akker-Scheek</dc:creator>
                <dc:creator>Klaus Wendt</dc:creator>
                <dc:creator>Ron Diercks</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2012, null:16</dc:source>
        <dc:date>2012-02-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-13-16</dc:identifier>
                                <prism:require>/content/figures/1471-2474-13-16-toc.gif</prism:require>
                <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>16</prism:startingPage>
        <prism:publicationDate>2012-02-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/13/15">
        <title>African American patients with gout: Efficacy and safety of febuxostat vs allopurinol</title>
        <description>Background:
African Americans are twice as likely as Caucasians to develop gout, but they are less likely to be treated with urate-lowering therapy (ULT). Furthermore, African Americans typically present with more comorbidities associated with gout, such as hypertension, obesity, and renal impairment. We determined the efficacy and safety of ULT with febuxostat or allopurinol in African American subjects with gout and associated comorbidities and in comparison to Caucasian gout subjects.
Methods:
This is a secondary analysis of the 6-month Phase 3 CONFIRMS trial. Eligible gouty subjects with baseline serum urate (sUA) [greater than or equal to]8.0 mg/dL were randomized 1:1:1 to receive febuxostat 40 mg, febuxostat 80 mg, or allopurinol (300 mg or 200 mg depending on renal function) daily. All subjects received gout flare prophylaxis. Primary efficacy endpoint was the proportion of subjects in each treatment group with sUA &lt;6.0 mg/dL at the final visit. Additional endpoints included the proportion of subjects with mild or with moderate renal impairment who achieved a target sUA &lt;6.0 mg/dL at final visit. Adverse events (AEs) were recorded throughout the study.
Results:
Of the 2,269 subjects enrolled, 10.0% were African American and 82.1% were Caucasian. African American subjects were mostly male (89.5%), obese (BMI [greater than or equal to]30 kg/m2; 67.1%), with mean baseline sUA of 9.8 mg/dL and mean duration of gout of 10.4 years. The proportions of African American subjects with a baseline history of diabetes, renal impairment, or cardiovascular disease were significantly higher compared to Caucasians (p &lt; 0.001). ULT with febuxostat 80 mg was superior to both febuxostat 40 mg (p &lt; 0.001) and allopurinol (p = 0.004). Febuxostat 40 mg was comparable in efficacy to allopurinol. Significantly more African American subjects with mild or moderate renal impairment achieved sUA &lt;6.0 mg/dL in the febuxostat 80 group than in either the febuxostat 40 mg or allopurinol group (p &lt; 0.05). Efficacy rates in all treatment groups regardless of renal function were comparable between African American and Caucasian subjects, as were AE rates.
Conclusions:
In African American subjects with significant comorbidities, febuxostat 80 mg is significantly more efficacious than either febuxostat 40 mg or allopurinol 200/300 mg. Febuxostat was well tolerated in this African American population. NCT00430248Please see related article: http://www.biomedcentral.com/1741-7015/10/15</description>
        <link>http://www.biomedcentral.com/1471-2474/13/15</link>
                <dc:creator>Alvin Wells</dc:creator>
                <dc:creator>Patricia MacDonald</dc:creator>
                <dc:creator>Solomon Chefo</dc:creator>
                <dc:creator>Robert Jackson</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2012, null:15</dc:source>
        <dc:date>2012-02-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-13-15</dc:identifier>
                                <prism:require>/content/figures/1471-2474-13-15-toc.gif</prism:require>
                <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>15</prism:startingPage>
        <prism:publicationDate>2012-02-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/13/14">
        <title>Investigation of first ray mobility during gait by kinematic fluoroscopic imaging - a novel method</title>
        <description>Background:
It is often suggested that sagittal instability at the first tarso-metatarsal joint level is a primary factor for hallux valgus and that sagittal instability increases with the progression of the deformity. The assessment of the degree of vertical instability is usually made by clinical evaluation while any measurements mostly refer to a static assessment of medial ray mobility (i.e. the plantar/dorsal flexion in the sagittal plane). Testing methods currently available cannot attribute the degree of mobility to the corresponding anatomical joints making up the medial column of the foot. The aim of this study was to develop a technique which allows for a quantification of the in-vivo sagittal mobility of the joints of the medial foot column during the roll-over process under full weight bearing.
Methods:
Mobility of first ray bones was investigated by dynamic distortion-free fluoroscopy (25 frames/s) of 14 healthy volunteers and 8 patients with manifested clinical instability of the first ray. A CAD-based evaluation method allowed the determination of mobility and relative displacements and rotations of the first ray bones within the sagittal plane during the stance phase of gait.
Results:
Total flexion of the first ray was found to be 13.63 (SD 6.14) mm with the healthy volunteers and 13.06 (SD 8.01) mm with the patients (resolution: 0.245 mm/pixel). The dorsiflexion angle was 5.27 (SD 2.34) degrees in the healthy volunteers and increased to 5.56 (SD 3.37) degrees in the patients. Maximum rotations were found at the naviculo-cuneiform joints and least at the first tarso-metatarsal joint level in both groups.
Conclusions:
Dynamic fluoroscopic assessment has been shown to be a valuable tool for characterisation of the kinematics of the joints of the medial foot column during gait.A significant difference in first ray flexion and angular rotation between the patients and healthy volunteers however could not be found.</description>
        <link>http://www.biomedcentral.com/1471-2474/13/14</link>
                <dc:creator>Heiner Martin</dc:creator>
                <dc:creator>Ulf Bahlke</dc:creator>
                <dc:creator>Albrecht Dietze</dc:creator>
                <dc:creator>Volker Zschorlich</dc:creator>
                <dc:creator>Klaus-Peter Schmitz</dc:creator>
                <dc:creator>Thomas Mittlmeier</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2012, null:14</dc:source>
        <dc:date>2012-02-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-13-14</dc:identifier>
                                <prism:require>/content/figures/1471-2474-13-14-toc.gif</prism:require>
                <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>14</prism:startingPage>
        <prism:publicationDate>2012-02-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/13/13">
        <title>Mechanical pain sensitivity of deep tissues in children - possible development of myofascial trigger points in children</title>
        <description>Background:
It is still unclear when latent myofascial trigger points (MTrPs) develop during early life. This study is designed to investigate the mechanical pain sensitivity of deep tissues in children in order to see the possible timing of the development of latent MTrPs and attachment trigger points (A-TrPs) in school children.
Methods:
Five hundreds and five healthy school children (age 4- 11 years) were investigated. A pressure algometer was used to measure the pressure pain threshold (PPT) at three different sites in the brachioradialis muscle: the lateral epicondyle at elbow (site A, assumed to be the A-TrP site), the mid-point of the muscle belly (site B, assumed to be the MTrP site), and the muscle-tendon junction as a control site (site C).
Results:
The results showed that, for all children in this study, the mean PPT values was significantly lower (p &lt; 0.05) at the assumed A-TrP site (site A) than at the other two sites, and was significantly lower (p &lt; 0.05) at the assumed MTrP site (site B) than at the control site (site C). These findings are consistent if the data is analyzed for different genders, different dominant sides, and different activity levels.
Conclusions:
It is concluded that a child had increased sensitivity at the tendon attachment site and the muscle belly (endplate zone) after age of 4 years. Therefore, it is likely that a child may develop an A-Trp and a latent MTrP at the brachioradialis muscle after the age of 4 years. The changes in sensitivity, or the development for these trigger points, may not be related to the activity level of children aged 7-11 years. Further investigation is still required to indentify the exact timing of the initial occurrence of a-Trps and latent MTrPs.Key words: myofascial trigger points, children, pressure pain threshold, algometry</description>
        <link>http://www.biomedcentral.com/1471-2474/13/13</link>
                <dc:creator>Ting-I Han</dc:creator>
                <dc:creator>Chang-Zern Hong</dc:creator>
                <dc:creator>Fang-Chuan Kuo</dc:creator>
                <dc:creator>Yueh-Ling Hsieh</dc:creator>
                <dc:creator>Li-Wei Chou</dc:creator>
                <dc:creator>Mu-Jung Kao</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2012, null:13</dc:source>
        <dc:date>2012-02-08T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-13-13</dc:identifier>
                                <prism:require>/content/figures/1471-2474-13-13-toc.gif</prism:require>
                <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>13</prism:startingPage>
        <prism:publicationDate>2012-02-08T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/13/12">
        <title>Radiographic knee osteoarthritis in ex-elite table tennis players </title>
        <description>Background:
Table tennis involves adoption of the semi-flexed knee and asymmetrical torsional trunk movements creating rotational torques on the knee joint which may predispose players to osteoarthritis (OA) of the knee. This study aims to compare = radiographic signs of knee OA and associated functional levels in ex-elite male table tennis players and control subjects.
Methods:
Study participants were 22 ex-elite male table tennis players (mean age 56.64 +/- 5.17 years) with 10 years of involvement at the professional level and 22 non-athletic males (mean age 55.63 +/- 4.08 years) recruited from the general population. A set of three radiographs taken from each knee were evaluated by an experienced radiologist using the Kellgren and Lawrence (KL) scale (0-4) to determine radiographic levels of OA severity. The intercondylar distance was taken as a measure of lower limb angulation. Participants also completed the pain, stiffness, and physical function categories of the Western Ontario and McMaster University Osteoarthritis Index (WOMAC) 3.1 questionnaire.
Results:
The results showed 78.3% of the ex-elite table tennis players and 36.3% of controls had varying signs of radiographic knee OA with a significant difference in the prevalence levels of definite radiographic OA (KL scale &gt;2) found between the two groups (P &lt; 0.001). Based on the WOMAC scores, 68.2% of the ex-elite table tennis players reported symptoms of knee pain compared with 27.3% of the controls (p = 0.018) though no significant differences were identified in the mean physical function or stiffness scores between the two groups. In terms of knee alignment, 73.7% of the ex-elite athletes and 32% of the control group had signs of altered lower limb alignment (genu varum) (p = 0.01). Statistical differences were found in subjects categorized as having radiographic signs of OA and altered lower limb alignment (p = 0.03).
Conclusions:
Ex-elite table tennis players were found to have increased levels of radiological signs of OA in the knee joint though this did not transpire through to altered levels of physical disability or knee stiffness in these players when compared with subjects from the general population suggesting that function in these players is not severely impacted upon.</description>
        <link>http://www.biomedcentral.com/1471-2474/13/12</link>
                <dc:creator>Reza Rajabi</dc:creator>
                <dc:creator>Gillian Johnson</dc:creator>
                <dc:creator>Mohammad Alizadeh</dc:creator>
                <dc:creator>Nazanin Meghdadi</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2012, null:12</dc:source>
        <dc:date>2012-02-06T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-13-12</dc:identifier>
                                <prism:require>/content/figures/1471-2474-13-12-toc.gif</prism:require>
                <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2012-02-06T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/13/11">
        <title>Pressure and pain In Systemic sclerosis/ Scleroderma - an evaluation of a simple intervention (PISCES): randomised controlled trial protocol</title>
        <description>Background:
Foot problems associated with Systemic Sclerosis (SSc)/Scleroderma have been reported to be both common and disabling. There are only limited data describing specifically, the mechanical changes occurring in the foot in SSc.  A pilot project conducted in preparation for this trial confirmed the previous reports of foot related impairment and reduced foot function in people with SSc and demonstrated a link to mechanical etiologies. To-date there have been no formal studies of interventions directed at the foot problems experienced by people with Systemic Sclerosis.The primary aim of this trial is to evaluate whether foot pain and foot-related health status in people with Systemic Sclerosis can be improved through the provision of a simple pressure-relieving insole.
Methods:
The proposed trial is a pragmatic, multicenter, randomised controlled clinical trial following a completed pilot study. In four participating centres, 140 consenting patients with SSc and plantar foot pain will be randomised to receive either a commercially available pressure relieving and thermally insulating insole, or a sham insole with no cushioning or thermal properties.The primary end point is a reduction in pain measured using the Foot Function Index Pain subscale, twelve weeks after the start of intervention. Participants will complete the primary outcome measure (Foot Function Index pain sub-scale) prior to randomisation and at twelve weeks post randomisation.Secondary outcomes include participant reported pain and disability as derived from the Manchester Foot Pain and Disability Questionnaire and plantar pressures with and without the insoles in situ.DiscussionThis trial protocol proposes a rigorous and potentially significant evaluation of a simple and readily provided therapeutic approach which, if effective, could be of a great benefit for this group of patients.Trial registrationCurrent Controlled Trials: ISRCTN02824122</description>
        <link>http://www.biomedcentral.com/1471-2474/13/11</link>
                <dc:creator>Begonya Alcacer-Pitarch</dc:creator>
                <dc:creator>Maya Buch</dc:creator>
                <dc:creator>Janine Gray</dc:creator>
                <dc:creator>Christopher Denton</dc:creator>
                <dc:creator>Ariane Herrick</dc:creator>
                <dc:creator>Nuria Navarro-Coy</dc:creator>
                <dc:creator>Howard Collier</dc:creator>
                <dc:creator>Lorraine Loughrey</dc:creator>
                <dc:creator>Sue Pavitt</dc:creator>
                <dc:creator>Heidi Siddle</dc:creator>
                <dc:creator>Jonathan Wright</dc:creator>
                <dc:creator>Philip Helliwell</dc:creator>
                <dc:creator>Paul Emery</dc:creator>
                <dc:creator>Anthony Redmond</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2012, null:11</dc:source>
        <dc:date>2012-02-06T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-13-11</dc:identifier>
                                <prism:require>/content/figures/1471-2474-13-11-toc.gif</prism:require>
                <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>11</prism:startingPage>
        <prism:publicationDate>2012-02-06T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/13/10">
        <title>Cervical radiculopathy: Study protocol of a randomised clinical trial evaluating the effect of mobilisations and exercises targeting the opening of intervertebral foramen [NCT01500044]</title>
        <description>Background:
Cervical radiculopathy is a common form of neck pain and has been shown to lead to severe disability. Clinical rehabilitation approaches for cervical radiculopathies commonly include exercise and manual therapy interventions targeting the opening of intervertebral foramen, but evidence regarding their effectiveness is scarce. The primary objective of this randomised clinical trial is to compare, in terms of pain and disability, a rehabilitation program targeting the opening of intervertebral foramen to a conventional rehabilitation program, for patients presenting acute or subacute cervical radiculopathies. The hypothesis is that the rehabilitation program targeting the opening of intervertebral foramen will be significantly more effective in reducing pain and disability than the conventional rehabilitation program.
Methods:
This study is a double-blind (participants and evaluators blinded) randomised clinical trial that will allow the comparison of patients with a cervical radiculopathy randomly assigned to one of two groups: one group will receive a 4-week rehabilitation program targeting the opening of intervertebral foramen, and the second group will receive a 4-week conventional rehabilitation program. Thirty-six subjects with cervical radiculopathy will be recruited from participating medical and physiotherapy clinics and will be evaluated at baseline, at the end of the 4-week program and four weeks following the end of the program. The primary outcome measure will be the validated Neck Disability Index questionnaire. Secondary outcome measures will include the short version of the Disabilities of the Arm, Shoulder and Hand questionnaire, a numerical pain rating scale, cervicothoracic mobility and patients&apos; perceived global rating of change. During the 4-week rehabilitation program, each participant will take part in eight physiotherapy treatment sessions (2 session/week) and will perform a home exercise program. A mixed-model, 2-way ANOVA will be used to analyze the effects of the rehabilitation programs.DiscussionControl trials are needed to define ideal intervention approaches in rehabilitation for this population. This randomised clinical trial will be the first study that directly compares a rehabilitation program targeting the opening of intervertebral foramen to a conventional rehabilitation program for patients with cervical radiculopathy. The results of this study may help to establish best clinical practice guidelines for this patient population.Trial registration: ClinicalTrials.gov Identifier - NCT01500044</description>
        <link>http://www.biomedcentral.com/1471-2474/13/10</link>
                <dc:creator>Pierre Langevin</dc:creator>
                <dc:creator>Jean-Sebastien Roy</dc:creator>
                <dc:creator>Francois Desmeules</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2012, null:10</dc:source>
        <dc:date>2012-01-31T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-13-10</dc:identifier>
                                <prism:require>/content/figures/1471-2474-13-10-toc.gif</prism:require>
                <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2012-01-31T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/13/9">
        <title>Early intervention for adolescents with Patellofemoral Pain Syndrome - a pragmatic cluster randomised controlled trial.</title>
        <description>Background:
Self-reported knee pain is highly prevalent among adolescents. As much as 50% of the non-specific knee pain may be attributed to Patellofemoral Pain Syndrome (PFPS). In the short term, exercise therapy appears to have a better effect than patient education consisting of written information and general advice on exercise or compared with placebo treatment. But the long-term effect of exercise therapy compared with patient education is conflicting. The purpose of this study is to examine the short- and long-term effectiveness of patient education compared with patient education and multimodal physiotherapy applied at a very early stage of the condition among adolescents.
Methods:
This study is a single blind pragmatic cluster randomised controlled trial. Four upper secondary schools have been invited to participate in the study (approximately 2500 students, aged 15-19 years). Students are asked to answer an online questionnaire regarding musculoskeletal pain. The students who report knee pain are contacted by telephone and offered a clinical examination by a rheumatologist. Subjects who fit the inclusion criteria and are diagnosed with PFPS are invited to participate in the study. A minimum of 102 students with PFPS are then cluster-randomised into two intervention groups based on which school they attend. Both intervention groups receive written information and education. In addition to patient education, one group receives multimodal physiotherapy consisting primarily of neuromuscular training of the muscles around the foot, knee and hip and home exercises.The students with PFPS fill out self-reported questionnaires at baseline, 3, 6, 12 and 24 months after inclusion in the study. The primary outcome measure is perception of recovery measured on a 7-point Likert scale ranging from &quot;completely recovered&quot; to &quot;worse than ever&quot; at 12 months.DiscussionThis study is designed to investigate the effectiveness of patient education compared with patient education combined with multimodal physiotherapy. If patient education and multimodal physiotherapy applied at an early stage of Patellofemoral Pain Syndrome proves effective, it may serve as a basis for optimising the clinical pathway for those suffering from the condition, where specific emphasis can be placed on early diagnosis and early treatment.Trial Registration: clinicaltrials.gov reference: NCT01438762</description>
        <link>http://www.biomedcentral.com/1471-2474/13/9</link>
                <dc:creator>Michael Rathleff</dc:creator>
                <dc:creator>Ewa Roos</dc:creator>
                <dc:creator>Jens Olesen</dc:creator>
                <dc:creator>Sten Rasmussen</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2012, null:9</dc:source>
        <dc:date>2012-01-27T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-13-9</dc:identifier>
                                <prism:require>/content/figures/1471-2474-13-9-toc.gif</prism:require>
                <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2012-01-27T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/13/8">
        <title>Reinforcing the role of the conventional C-arm - A novel method for simplified distal interlocking</title>
        <description>Background:
The common practice for insertion of distal locking screws of intramedullary nails is a freehand technique under fluoroscopic control. The process is technically demanding, time-consuming and afflicted to considerable radiation exposure of the patient and the surgical personnel. A new concept is introduced utilizing information from within conventional radiographic images to help accurately guide the surgeon to place the interlocking bolt into the interlocking hole. The newly developed technique was compared to conventional freehand in an operating room (OR) like setting on human cadaveric lower legs in terms of operating time and radiation exposure.
Methods:
The proposed concept (guided freehand), generally based on the freehand gold standard, additionally guides the surgeon by means of visible landmarks projected into the C-arm image. A computer program plans the correct drilling trajectory by processing the lens-shaped hole projections of the interlocking holes from a single image. Holes can be drilled by visually aligning the drill to the planned trajectory. Besides a conventional C-arm, no additional tracking or navigation equipment is required.Ten fresh frozen human below-knee specimens were instrumented with an Expert Tibial Nail (Synthes GmbH, Switzerland). The implants were distally locked by performing the newly proposed technique as well as the conventional freehand technique on each specimen. An orthopedic resident surgeon inserted four distal screws per procedure. Operating time, number of images and radiation time were recorded and statistically compared between interlocking techniques using non-parametric tests.
Results:
A 58% reduction in number of taken images per screw was found for the guided freehand technique (7.4 +/- 3.4) (mean +/- SD) compared to the freehand technique (17.6 +/- 10.3) (p &lt; 0.001). Total radiation time (all 4 screws) was 55% lower for the guided freehand technique compared to conventional freehand (p = 0.001). Operating time per screw (from first shot to screw tightened) was on average 22% reduced by guided freehand (p = 0.018).
Conclusions:
In an experimental setting, the newly developed guided freehand technique for distal interlocking has proven to markedly reduce radiation exposure when compared to the conventional freehand technique. The method utilizes established clinical workflows and does not require cost intensive add-on devices or extensive training. The underlying principle carries potential to assist implant positioning in numerous other applications within orthopedics and trauma from screw insertions to placement of plates, nails or prostheses.</description>
        <link>http://www.biomedcentral.com/1471-2474/13/8</link>
                <dc:creator>Markus Windolf</dc:creator>
                <dc:creator>Josh Schroeder</dc:creator>
                <dc:creator>Ladina Fliri</dc:creator>
                <dc:creator>Benno Dicht</dc:creator>
                <dc:creator>Meir Liebergall</dc:creator>
                <dc:creator>Geoff Richards</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2012, null:8</dc:source>
        <dc:date>2012-01-25T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-13-8</dc:identifier>
                                <prism:require>/content/figures/1471-2474-13-8-toc.gif</prism:require>
                <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2012-01-25T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/13/7">
        <title>Triggers for an episode of sudden onset low back pain: study protocol</title>
        <description>Background:
Most research on risk factors for low back pain has focused on long term exposures rather than factors immediately preceding the onset of low back pain. The aim of this study is to quantify the transient increase in risk of a sudden episode of low back pain associated with acute exposure to a range of common physical and psychological factors.Methods/design: This study uses a case-crossover design. One thousand adults with a sudden onset of low back pain presenting to primary care clinicians will be recruited. Basic demographic and clinical information including exposure to putative triggers will be collected using a questionnaire. These triggers include exposure to hazardous manual tasks, physical activity, a slip/trip or fall, consumption of alcohol, sexual activity, being distracted, and being fatigued or tired. Exposures in the case window (0-2 hours from the time when participants first notice their back pain) will be compared to exposures in two control time-windows (one 24-26 hours and another 48-50 hours before the case window).DiscussionThe completion of this study will provide the first-research based estimates of the increase in risk of a sudden episode of acute low back pain associated with transient exposure to a range of common factors thought to trigger low back pain.</description>
        <link>http://www.biomedcentral.com/1471-2474/13/7</link>
                <dc:creator>Daniel Steffens</dc:creator>
                <dc:creator>Manuela Ferreira</dc:creator>
                <dc:creator>Christopher Maher</dc:creator>
                <dc:creator>Jane Latimer</dc:creator>
                <dc:creator>Bart Koes</dc:creator>
                <dc:creator>Fiona Blyth</dc:creator>
                <dc:creator>Paulo Ferreira</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2012, null:7</dc:source>
        <dc:date>2012-01-24T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-13-7</dc:identifier>
                                <prism:require>/content/figures/1471-2474-13-7-toc.gif</prism:require>
                <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>7</prism:startingPage>
        <prism:publicationDate>2012-01-24T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

